CME Webcast Discusses New Therapies for Lung Cancer

OSUWexnerbloglogo2014 CME Webcast Discusses New Therapies for Lung Cancer. On this CME webcast, we’re going to update you on the medical management of lung cancer and focus on non-small cell lung cancer. Joining our moderator in the studio is medical oncologist at the James Cancer Hospital and Professor of Internal Medicine from the Ohio State University, Dr. David Carbone.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review some of the latest practice-changing findings in the management of lung cancer; and Understand the basic principles of workup and initial lung cancer management decisions.

You’ll also learn about the following:

  • Classifying non-small cell lung cancer
  • Common side effects of driver-targeted therapies
  • What the primary care physician needs to know about co-managing patients taking driver-targeted therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

 

Gain A Better Understanding of Psoriasis on CME Webcast

OSUWexnerbloglogo2014 Gain A Better Understanding of Psoriasis on CME Webcast. Over the centuries, thousands of treatments have been tried and thousands of treatments have failed. But the good news is that in the past few years there have been effective new biologic agents developed that are offering hope to patients with the most severe cases of psoriasis. Joining us on our webcast to discuss the diagnosis and management of psoriasis is dermatologist and Assistant Professor of Internal Medicine, Dr. Jessica Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the different types of psoriasis and how to effectively treat them; DESCRIBE the pathogenesis of psoriasis and how it correlates with the newest therapies; and IDENTIFY frequent psoriasis co-morbidities that affect medication management.

You’ll also learn about the following:

  • The etiology of psoriasis
  • New directions in treating psoriasis
  • The role of skin biopsy
  • Psoriasis versus eczema
  • Long-term prognosis for patients with psoriasis
  • Relationship of diet, exercise, and sunlight with psoriasis
  • Deodorants and common skin lotions
  • Swimming with psoriasis
  • Treatment of psoriatic arthritis
  • Precautions for patients taking methotrexate
  • Genital psoriasis and sexual health

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

The Diabetic Foot Webcast Educates Primary Care Physicians

OSUWexnerbloglogo2014 The Diabetic Foot Webcast Educates Primary Care Physicians. On this CME webcast, you’re going to learn everything a primary care physician needs to know about the diabetic foot. Joining our moderator, in the studio, is podiatrist and Assistant Professor of Orthopedics, Dr. Michael Anthony and also podiatrist and Assistant Professor of Orthopedics, Dr. Said Atway.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: EVALUATE the impact of Diabetes on the lower extremity; DISCUSS warning signs or symptoms which may result in Diabetic ulceration; UNDERSTAND when to refer a diabetic patient to a foot specialist; and HOW to work up an at risk diabetic patient or a patient with a foot wound.

You’ll also learn about the following:

  • Why diabetics get foot disorders
  • Foot disorders that diabetics get
  • Bacterial cultures of diabetic foot infections
  • Radiographic imaging of diabetic foot infections
  • When to admit
  • The role of hyperbaric oxygen in treatment of diabetic foot ulcers
  • Footwear for patients with diabetes

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Treatment of Opioid Dependency on CME Webcast

OSUWexnerbloglogo2014 Learn About Treatment of Opioid Dependency on CME Webcast. In the 55 years since Dr. Dole began his ground breaking research in the treatment of opioid addiction, we have come a long way toward better understanding the effects of opioids and toward developing effective treatment for opioid addiction. However all of these advances have been eclipsed by increased opioid use in the United States fueled by the unbridled prescription of opioid pain relievers in the 1990’s and 2000’s, by price reduction in heroin on the streets, and by recent availability of newer high potency opioids such as fentanyl. But there is hope and on this CME webcast, we’re going to hear about some of the effective solutions to opioid addiction. Here with me in the studio is addiction specialist and Assistant Professor of Psychiatry, Dr. Casia Horseman.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the assessment of opioid use disorder; and DESCRIBE pharmacological and psychosocial treatments for opioid use disorder.

You’ll also learn about the following:

  • Demographics of opioid addiction
  • Why opioid use is such a growing problem
  • Why patients relapse
  • Treatment selection strategies
  • The role of the primary care physician in the treatment of opioid use disorder
  • Insurance coverage for treatment
  • Time-limited opioid prescriptions to relieve withdrawal symptoms
  • Inpatient management of the patient already on medication treatment for opioid addiction

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Discusses Vasculitis and What The Primary Care Physician Needs To Know

OSUWexnerbloglogo2014 On-line Education Discusses Vasculitis and What The Primary Care Physician Needs To Know. Vasculitides such as granulomatosis with polyangiitis are potentially deadly diseases and patients will usually first present to their primary care physician with signs and symptoms of vasculitis. But these diseases can be difficult to diagnose so today on MedNet, we’re going to help you to be able to identify vasculitis in your patients and give you an overview of the treatment of vasculitis. First, to tell you about pulmonary manifestations of vasculitis is pulmonologist and Assistant Professor of Internal Medicine, Dr. Lynn Fussner. And then, to tell you about renal manifestations of vasculitis is nephrologist and Assistant Professor of Internal Medicine Dr. Salem Almaani. And finally, to share about the treatment of vasculitis is rheumatologist and Assistant Professor of Internal Medicine, Dr. Alexa Meara.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the classification and defining features of ANCA-associated vasculitis; and HIGHLIGHT clinical findings that could suggest sinopulmonary manifestations of vasculitis.

You’ll also learn about the following:

  • Presenting signs and symptoms of vasculitis
  • Prognosis of vasculitis
  • When to stop treatment
  • Microscopic polyangiitis
  • Distinguishing between vasculitides by kidney biopsy
  • Whether vasculitis patients with ESRD need to be treated

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.